AAV Vectors & Virus
As a leader in Adeno-Associated Virus (AAV) technology, abm offers an affordable, comprehensive collection of human, mouse and rat genes cloned into ready-to-use AAV vectors or packaged AAV virus (serotypes 1-11) for gene over-expression studies within a wide range of host cells.
Search our Ready-to-Use Libraries by selecting the appropriate dropdowns and entering the gene name, symbol or accession number:
Search AAV Collection
AAV Collection
We offer over 40,000 human, mouse and rat genes available in AAV vector or virus format with a wide choice of promoters, reporters, and serotypes.
Advantages of the AAV System:
- Used as a promising candidate for gene therapy
- Does not elicit significant immune responses in vivo
- Broad tropism – tissue specificity with different AAV serotypes
- No integration into the host genome
- Ability to transduce both proliferating and quiescent cells
- Long-term expression in non-dividing cells
Can’t find the AAV construct you’re looking for? Design your own vector using our Plasmid Planner.
Check out our additional AAV Collections:
Additional Information
Which serotype should I use?
Try our AAV Serotype Blast Kit or selection of control viruses to optimize your experiments.
The Adeno-associated Virus(AAV)
Learning resources
Our AAV infectivity Data Speaks for Itself
EGFP expression in lumbar neuronal cells 4 weeks after intrathecal injection into mice (Left), and seen with β-tubulin (red) and DAPI (blue) overlay (Right). Courtesy of Dr. D Lopes, King’s college London.
Documents
Top Publications
01
Hypothalamic stem cells control ageing speed partly through exosomal miRNAs.
Zhang, Y et al.
Nature 548(7665):52-57 (2017).
02
Sestrin2 prevents age-related intolerance to post myocardial infarction via AMPK/PGC-1α pathway.
Li, J., et al
J Mol Cell Cardiol. 115:170-178 (2018).
03
Long Noncoding RNA Kcna2 Antisense RNA Contributes to Ventricular Arrhythmias via Silencing Kcna2 in Rats With Congestive Heart Failure.
Wang, L.S., et al.
J Am Heart Assoc. 6(12) pii: e005965 (2017).
FAQs
